|
CHAF1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.395390E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.976000E-02 |
| Normal-vs-Stage2 |
1.038000E-02 |
| Normal-vs-Stage3 |
2.499000E-01 |
| Normal-vs-Stage4 |
8.401200E-01 |
| Stage1-vs-Stage2 |
1.489780E-01 |
| Stage1-vs-Stage3 |
8.148000E-01 |
| Stage1-vs-Stage4 |
8.877800E-02 |
| Stage2-vs-Stage3 |
2.641600E-01 |
| Stage2-vs-Stage4 |
1.790070E-02 |
| Stage3-vs-Stage4 |
2.306800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.437430E-01 |
| Normal-vs-AfricanAmerican |
2.990600E-01 |
| Normal-vs-Asian |
8.393600E-01 |
| Caucasian-vs-AfricanAmerican |
9.505200E-01 |
| Caucasian-vs-Asian |
4.762800E-01 |
| AfricanAmerican-vs-Asian |
5.045200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.338800E-01 |
| Normal-vs-Female |
2.697600E-02 |
| Male-vs-Female |
8.936400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.711200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.793400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.594300E-02 |
| Normal-vs-Age(81-100Yrs) |
4.494400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.067000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.211800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.776000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.137600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.927800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.767000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.179200E-01 |
| Normal-vs-Grade 2 |
3.785800E-02 |
| Normal-vs-Grade 3 |
1.252230E-01 |
| Normal-vs-Grade 4 |
5.989200E-01 |
| Grade 1-vs-Grade 2 |
7.507400E-01 |
| Grade 1-vs-Grade 3 |
6.710800E-01 |
| Grade 1-vs-Grade 4 |
2.317400E-01 |
| Grade 2-vs-Grade 3 |
6.566400E-01 |
| Grade 2-vs-Grade 4 |
2.737500E-02 |
| Grade 3-vs-Grade 4 |
5.575900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.78529999999411E-05 |
| Normal-vs-ccB subtype |
3.457800E-01 |
| ccA subtype-vs-ccB subtype |
2.53940002359343E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.929390E-01 |
| Normal-vs-N1 |
8.789800E-02 |
| N0-vs-N1 |
4.863300E-03 |
|
|
